Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

JTE 607

Known as: JTE-607 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
JTE-607 is a small molecule that was developed as an inflammatory cytokine inhibitor and also as an anti-leukemia reagent for… Expand
2011
2011
It is generally regarded that the excessive production of cytokines plays an important role in the pathology of autoimmune… Expand
2008
2008
Renal ischemia/reperfusion (I/R) injury is one of the main causes of postoperative renal failure. Activated neutrophils are… Expand
2006
2006
OBJECTIVE Accumulating findings suggest that in acute myeloid leukemia (AML) patients, proinflammatory cytokines and growth… Expand
2004
2004
The present study was designed to clarify the effects of (-)-ethyl N-[3,5-dichloro-2-hydroxy-4-[2-(4-methyl-piperazin-1-yl)ethoxy… Expand
2004
2004
Actions of glucocorticoids, cyclosporine A, and JTE-607 [(-)-ethyl-N-{3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2004
2004
BACKGROUND Myocardial ischemia-reperfusion injury is a main cause of postoperative cardiac dysfunction, and a burst of… Expand
2002
2002
Abstract.Objective and design: JTE-607, a multiple cytokine inhibitor, was evaluated in lipopolysaccharide (LPS)-induced acute… Expand
  • figure 2
  • figure 1
  • figure 3
  • table 1
  • figure 4
1999
1999
Abstract.Objective and Design: We investigated the effect of a novel N-benzoyl-L-phenylalanine derivative compound (JTE-607) on… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3